US Broker Ratings

HealthStream, Inc. (HSTM) Stock Analysis: Unlocking a 60% Upside Potential

HealthStream, Inc. (NASDAQ: HSTM), a leading provider in the health information services sector, offers an intriguing investment opportunity as it stands poised for significant growth. With a current market capitalization..

Replimune Group, Inc. (REPL) Stock Analysis: Exploring an 85% Potential Upside in the Biotech Sector

Investors eyeing the biotechnology sector for promising opportunities might find Replimune Group, Inc. (NASDAQ: REPL) a compelling case, especially given its impressive potential upside of 85.53% based on current analyst..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (OMI), a key player in the healthcare sector, is drawing attention from investors due to its significant upside potential, pegged at 94.29%. This notable figure is..

Cogent Biosciences, Inc. (COGT) Investor Outlook: 42% Potential Upside Drives Interest in Biotech Innovator

Investors with an eye on the biotechnology sector may find Cogent Biosciences, Inc. (NASDAQ: COGT) a compelling opportunity. With a market capitalization of $5.48 billion, this American biotech company is..

CorMedix Inc. (CRMD) Stock Analysis: A Biotech Company with Over 100% Potential Upside

Investors seeking opportunities in the biotechnology sector might find CorMedix Inc. (NASDAQ: CRMD) an intriguing candidate. With a current market capitalization of $579.1 million, this healthcare sector player is gaining..

GH Research PLC (GHRS) Stock Analysis: A Biotech Pioneer with a 146.95% Upside Potential

GH Research PLC (NASDAQ: GHRS), an emerging player in the biotechnology sector, has garnered significant attention from the investment community, primarily due to its promising drug pipeline and substantial upside..

Delcath Systems, Inc. (DCTH) Investor Outlook: Analyzing a 149.81% Potential Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its robust potential upside of 149.81%. Situated at the..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Exploring a 37% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK) has captured the attention of investors with its distinctive approach to treating severe genetic diseases. As a pioneering entity in the biotechnology sector, Stoke Therapeutics..

Altimmune, Inc. (ALT) Investor Outlook: Huge 259% Upside Potential as Analysts Bet Big on Biotech Breakthrough

For investors eyeing opportunities in the dynamic healthcare sector, Altimmune, Inc. (NASDAQ: ALT) presents a compelling case with its robust potential upside of 259.08%. This Gaithersburg, Maryland-based clinical-stage biopharmaceutical company..

Arvinas, Inc. (ARVN) Stock Analysis: Navigating Potential Amidst Biotechnology Challenges

Arvinas, Inc. (NASDAQ: ARVN) is an intriguing company within the biotechnology sector, known for its innovative approach to drug development. With a market capitalization of approximately $951.49 million, this U.S.-based..

Auna SA (AUNA) Stock Analysis: 77% Potential Upside Captures Investor Attention

Auna SA (AUNA), a healthcare service provider with a significant footprint in Latin America, is garnering attention from investors due to its impressive potential upside of 77.07%, as highlighted by..

Amylyx Pharmaceuticals, Inc. (AMLX): Investor Outlook with 55.68% Potential Upside

Amylyx Pharmaceuticals, Inc. (AMLX), a clinical-stage pharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the healthcare sector with its innovative approach to treating neurodegenerative and endocrine diseases. Specializing..

Beta Bionics, Inc. (BBNX) Stock Analysis: Strong Buy Ratings Signal 117% Upside Potential

Beta Bionics, Inc. (NASDAQ: BBNX), a promising player in the medical devices sector, has garnered significant attention from investors due to its innovative solutions aimed at enhancing the lives of..

Anavex Life Sciences Corp. (AVXL)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `502 Bad Gateway` response: 502 Bad Gateway 502 Bad Gateway clou (truncated…)

..

LENZ Therapeutics, Inc. (LENZ): A Biotech Stock with a Potential Upside of Over 267%

For investors with an eye on the biotechnology sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) presents an intriguing opportunity. Operating out of Solana Beach, California, this biopharmaceutical company is on the..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unveiling a 136% Potential Upside Amidst Biotech Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR) is a compelling name in the biopharmaceutical landscape, especially for investors seeking high-risk, high-reward opportunities. As a clinical-stage company, Vir Biotechnology focuses on the discovery..

Eton Pharmaceuticals (ETON): Exploring a 109% Potential Upside with a Strong Buy Consensus

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) has positioned itself as a compelling player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic medicines. With a..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Through a 27% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands out in the biotechnology sector with its innovative contributions to drug and vaccine development. With a market capitalization of $1.13 billion, this San..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a Potential 286% Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is a name that continues to intrigue investors within the biotechnology sector due to its cutting-edge focus on cell therapies for cancer treatment. With a..

Simulations Plus, Inc. (SLP) Stock Analysis: A Deeper Look at its 74% Potential Upside

Simulations Plus, Inc. (NASDAQ: SLP) stands at the intriguing intersection of healthcare and technology, specializing in cutting-edge software solutions for drug discovery and development. As a prominent player in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds